Financhill
Back

8x8 Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
29

EGHT
8x8

Last Price:
2.03
Seasonality Move:
5.66%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
29
8x8 (EGHT) is a Sell

Is 8x8 a Buy, Sell or Hold?

  • The current 8x8 [EGHT] share price is $2.02. The Score for EGHT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • EGHT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EGHT Stock Price Chart

What is 8x8's stock price today?

  • The 8x8 share price today is $2.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGHT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

EGHT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 33.82 Sell
Chaikin Money Flow: 2445117 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.23 - 2.83) Sell
Bollinger Bands (100): (2.32 - 2.88) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

EGHT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.16 Sell
20-day SMA: 2.47 Sell
50-day SMA: 2.45 Sell
200-day SMA: 2.8 Sell
8-day EMA: 2.14 Sell
20-day EMA: 2.35 Sell
50-day EMA: 2.49 Sell
200-day EMA: 2.96 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

8x8 Earnings Growth & EGHT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.14 per share, and a decrease next year of $0.05 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

8x8 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):